167 related articles for article (PubMed ID: 7634364)
1. Plasmalogen oxidation in human serum lipoproteins.
Felde R; Spiteller G
Chem Phys Lipids; 1995 Jun; 76(2):259-67. PubMed ID: 7634364
[TBL] [Abstract][Full Text] [Related]
2. Plasmalogens and their oxidative degradation products in low and high density lipoprotein.
Jira W; Spiteller G
Chem Phys Lipids; 1996 Mar; 79(2):95-100. PubMed ID: 8640904
[TBL] [Abstract][Full Text] [Related]
3. Detection of plasmalogen from plasma low density lipoprotein and high density lipoprotein in carp, Cyprinus carpio, and rainbow trout, Oncorhynchus mykiss.
Yamaguchi T; Miyamoto K; Yagi S; Horigane A; Sato M; Takeuchi M
Comp Biochem Physiol A Mol Integr Physiol; 2000 Nov; 127(3):339-46. PubMed ID: 11118943
[TBL] [Abstract][Full Text] [Related]
4. Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation.
Ikuta A; Sakurai T; Nishimukai M; Takahashi Y; Nagasaka A; Hui SP; Hara H; Chiba H
Clin Chim Acta; 2019 Jun; 493():1-7. PubMed ID: 30796899
[TBL] [Abstract][Full Text] [Related]
5. Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat.
Newman JW; Kaysen GA; Hammock BD; Shearer GC
J Lipid Res; 2007 Aug; 48(8):1792-800. PubMed ID: 17496268
[TBL] [Abstract][Full Text] [Related]
6. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis.
Neuzil J; Christison JK; Iheanacho E; Fragonas JC; Zammit V; Hunt NH; Stocker R
J Lipid Res; 1998 Feb; 39(2):354-68. PubMed ID: 9507996
[TBL] [Abstract][Full Text] [Related]
7. Does a diet high or low in fat influence the oxidation potential of VLDL, LDL and HDL subfractions?
McEneny J; McPherson P; Spence M; Bradley U; Blair S; McKinley M; Young I; Hunter S
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):612-8. PubMed ID: 22405535
[TBL] [Abstract][Full Text] [Related]
8. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
Chiu HC; Jeng JR; Shieh SM
Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
[TBL] [Abstract][Full Text] [Related]
9. Epoxidation of plasmalogens: source for long-chain alpha-hydroxyaldehydes in subcellular fractions of bovine liver.
Loidl-Stahlhofen A; Hannemann K; Felde R; Spiteller G
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):807-12. PubMed ID: 7639697
[TBL] [Abstract][Full Text] [Related]
10. Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.
Takeda H; Koike T; Izumi Y; Yamada T; Yoshida M; Shiomi M; Fukusaki E; Bamba T
J Biosci Bioeng; 2015 Oct; 120(4):476-82. PubMed ID: 26162515
[TBL] [Abstract][Full Text] [Related]
11. Surfactant-based homogeneous assay for the measurement of triglyceride concentrations in VLDL and intermediate-density lipoprotein.
Okada M; Saito T; Yoshimura H; Noguchi Y; Ito T; Sasaki H; Hama H
Clin Chem; 2005 Oct; 51(10):1804-10. PubMed ID: 16081508
[TBL] [Abstract][Full Text] [Related]
12. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
Moriel P; Okawabata FS; Abdalla DS
IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
[TBL] [Abstract][Full Text] [Related]
13. Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in preterm infant formulas on the fatty acid content of lipoprotein lipids.
Clandinin MT; Van Aerde JE; Parrott A; Field CJ; Euler AR; Lien E
Acta Paediatr; 1999 Aug; 88(8):890-6. PubMed ID: 10503691
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.
Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Båvenholm P; Frostegård J
Scand J Rheumatol; 2009; 38(3):184-9. PubMed ID: 19165647
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipid transport in the horse (Equus caballus).
Watson TD; Packard CJ; Shepherd J
Comp Biochem Physiol B; 1993 Sep; 106(1):27-34. PubMed ID: 8403851
[TBL] [Abstract][Full Text] [Related]
17. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
[TBL] [Abstract][Full Text] [Related]
18. Remodeling of human plasma lipoproteins by detergent perturbation.
Pownall HJ
Biochemistry; 2005 Jul; 44(28):9714-22. PubMed ID: 16008356
[TBL] [Abstract][Full Text] [Related]
19. Effect of estradiol on serum triglyceride lipoprotein levels and fatty acid composition in castrated rats.
Ginci G; Arezzini L; Terzuoli L; Pizzichini M; Marinello E
Horm Metab Res; 1997 Oct; 29(10):504-6. PubMed ID: 9405977
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance.
Hyötyläinen T; Mattila I; Wiedmer SK; Koivuniemi A; Taskinen MR; Yki-Järvinen H; Orešič M
Mol Biosyst; 2012 Oct; 8(10):2559-65. PubMed ID: 22722885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
